Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: A novel mechanism of glucagon-stimulated lipolysis?

Diabetologia

Volumn 56, Issue 3, 2013, Pages 588-597

  Arafat, A M ^a,b   Kaczmarek, P ^c   Skrzypski, M ^a,c   Pruszynska Oszmalek E ^c   Kolodziejski P ^c   Szczepankiewicz, D ^c   Sassek, M ^a,c   Wojciechowicz, T ^c   Wiedenmann, B ^a   Pfeiffer, A F H ^a,b   Nowak, K W ^c   Strowski, M Z ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Adipocytes; Animal study; Endocrine pancreas; Glucose homeostasis; Hepatocytes; Human study; Secretion; Type 1 diabetes

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCAGON; INSULIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; RAT;

3T3-L1 CELLS; ADULT; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCAGON; HUMANS; INSULIN; LIPOLYSIS; MALE; MICE; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84876558435     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2803-y     Document Type: Article

References (36)

1. Kharitonenkov A, Shiyanova TL, Koester A et al (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115:1627-1635
2. Nishimura T, Nakatake Y, Konishi M, Itoh N (2000) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492:203-206
3. Inagaki T, Dutchak P, Zhao G et al (2007) Endocrine regulation of the fasting response by PPAR alpha-mediated induction of fibroblast growth factor 21. Cell Metab 5:415-425
4. Potthoff MJ, Inagaki T, Satapati S et al (2009) FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 106:10853-10858
5. Hotta Y, Nakamura H, Konishi M et al (2009) Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150:4625-4633
6. Arner P, Pettersson A, Mitchell PJ, Dunbar JD, Kharitonenkov A, Ryden M (2008) FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. FEBS Lett 582:1725-1730
7. Zhang X, Yeung DC, Karpisek M et al (2008) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57:1246-1253
8. Berglund ED, Li CY, Bina HA et al (2009) Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 150:4084-4093
9. Lefebvre PJ, Luyckx AS (1969) Effect of insulin on glucagon enhanced lipolysis in vitro. Diabetologia 5:195-197
10. Perea A, Clemente F, Martinell J, Villanueva-Penacarrillo ML, Valverde I (1995) Physiological effect of glucagon in human isolated adipocytes. Horm Metab Res 27:372-375
11. Harmon JS, Sheridan MA (1992) Effects of nutritional state, insulin, and glucagon on lipid mobilization in rainbow trout, Oncorhynchus mykiss. Gen Comp Endocrinol 87:214-221
12. Uebanso T, Taketani Y, Fukaya M et al (2009) Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. Am J Physiol Endocrinol Metab 297:E76-E84
13. Uebanso T, Taketani Y, Yamamoto H et al (2011) Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS One 6:e22976
14. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E (2007) Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5:426-437
15. Berglund ED, Kang L, Lee-Young RS et al (2010) Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo. Am J Physiol Endocrinol Metab 299:E607-E614
16. Longuet C, Sinclair EM, Maida A et al (2008) The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab 8:359-371
17. Mai K, Andres J, Biedasek K et al (2009) Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes 58:1532-1538
18. Mai K, Bobbert T, Groth C et al (2010) Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin. Am J Physiol Endocrinol Metab 299:E126-E130
19. Arafat MA, Otto B, Rochlitz H et al (2005) Glucagon inhibits ghrelin secretion in humans. Eur J Endocrinol 153:397-402
20. Arafat AM, Perschel FH, Otto B et al (2006) Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level. J Clin Endocrinol Metab 91:3528-3533
21. Jesmin S, Zaedi S, Maeda S, Yamaguchi I, Goto K, Miyauchi T (2006) Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats. Exp Biol Med (Maywood) 231:925-931
22. Kim NN, Stankovic M, Cushman TT, Goldstein I, Munarriz R, Traish AM (2006) Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers. BMC Physiol 6:4
23. Wu KK, Huan Y (2008) Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol (Suppl 40):5.47.1-5.47.14
24. Berger J, Tanen M, Elbrecht A et al (2001) Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 276:12629-12635
25. Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83
26. Rodbell M (1964) Metabolism of isolated fat cells. I. effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380
27. Skrzypski M, Le T, Kaczmarek P et al (2011) Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes. Diabetologia 54:1841-1852
28. Nugent C, Prins JB, Whitehead JP et al (2001) Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol Endocrinol 15:1729-1738
29. Cherrington AD (1997) Chapter 10: the metabolic actions of glucagon. In: Draznin B, Rizza B (eds) Clinical research in diabetes and obesity, vol. 1. Methods, assessment and metabolic regulation. Part II: effects of hormones on substrate metabolism. Humana Press, Totowa, pp 221-242
30. Hojman P, Pedersen M, Nielsen AR et al (2009) Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 58:2797-2801
31. Iwanij V, Vincent AC (1990) Characterization of the glucagon receptor and its functional domains using monoclonal antibodies. J Biol Chem 265:21302-21308
32. Watanabe M, Hayasaki H, Tamayama T, Shimada M (1998) Histologic distribution of insulin and glucagon receptors. Braz J Med Biol Res 31:243-256
33. Svoboda M, Tastenoy M, Vertongen P, Robberecht P (1994) Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Mol Cell Endocrinol 105:131-137
34. Reinehr T, Woelfle J, Wunsch R, Roth CL (2012) Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab 97:2143-2150
35. Chen W, Hoo RL, Konishi M et al (2011) Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. J Biol Chem 286:34559-34566
36. Herlihy OM, Perros P (2000) Elevated serum growth hormone in a patient with type 1 diabetes: a diagnostic dilemma. Diabetes Metab Res Rev 16:211-216